Mizuho analyst Graig Suvannavejh raised the firm’s price target on Immatics (IMTX) to $19 from $16 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMTX:
- Immatics Appoints Amie Krause as Chief People Officer Amidst Commercial Transition
- Immatics appoints Krause as Chief People Officer
- Immatics’ Promising Efficacy and Strategic Positioning Support Buy Rating
- Immatics Reports Promising Anzu-cel Results in Uveal Melanoma
- Immatics highlights anti-tumor activity of anzu-cel PRAME cell therapy